🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Almost 15% of Americans have chronic kidney disease (CKD), with an even hig...
Status
Completed
Location
Michael E. DeBakey VA Medical Center, Houston, TX
Start Date
2023-02-01
Trial ID
NCT05171686
The purpose of this research study is to compare the effects (good and bad)...
Status
Terminated
Location
University of Cincinnati/University Hospital
Start Date
2011-11
Trial ID
NCT01457053
Treatments Being Tested
The primary objective of this study is to assess whether the urinary sodium...
Status
Terminated
Location
Ziekenhuis Oost-Limburg
Start Date
2014-09
Trial ID
NCT02288819
Treatments Being Tested
TRANSFORM-HF is a large-scale, pragmatic, randomized, unblinded clinical ef...
Status
Completed
Location
Russel Medical Center
Start Date
2018-07-11
Trial ID
NCT03296813
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus res...
Status
Completed
Location
University of Utah
Start Date
2020-01-19
Trial ID
NCT04467931
Treatments Being Tested
Almost 15% of Americans have chronic kidney disease (CKD), with an even hig...
Status
Withdrawn
Location
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Start Date
2020-08-11
Trial ID
NCT04192110
Treatments Being Tested
The objective of this study is to prospectively compare decongestive therap...
Status
Completed
Location
University Medical Center Groningen
Start Date
2024-05-17
Trial ID
NCT06362668
This study aims to compare two medications, acetazolamide and metolazone, a...
Status
Unknown
Location
National Heart Institute
Start Date
2024-07-01
Trial ID
NCT06414759
Treatments Being Tested
The primary objective of this study is to learn whether a morning dose of e...
Status
Completed
Location
Future Life Clinical Trials
Start Date
2025-05-28
Trial ID
NCT06995144
Treatments Being Tested